Arixtra Study in Percutaneous Coronary Intervention: A Randomized Evaluation - ASPIRE (Study in PCI)

Description:

The goal of the trial was to evaluate the safety and efficacy of treatment with fondaparinux, a synthetic factor Xa inhibitor, compared with unfractionated heparin (UFH) among patients undergoing percutaneous coronary intervention (PCI).